F-STAR THERAPEUTICS INC (FSTX)

US30315R1077 - Common Stock

7.12  0 (0%)

After market: 7.12 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
11.26M21.167M
87.98%
4.093M
-80.66%
EBITDA
YoY % growth
-32.66M
-15.90%
-21.25M
34.94%
-30.072M
-41.52%
-53.754M
-78.75%
N/AN/AN/A
EBIT
YoY % growth
-33.02M
-15.98%
-22.39M
32.19%
-30.714M
-37.18%
-56.986M
-85.54%
Operating Margin
N/A-198.85%-145.10%-1,392.29%
EPS
YoY % growth
-5.88
7.55%
-6.54
-11.22%
-2.01
69.27%
-2.81
-39.55%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
-0.56
-217.41%
Revenue
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-15.09M
-449.06%
N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth
-0.84
-61.54%
-0.80-0.04-4.58%
Q2 2022
Q2Q % growth
-0.88
1.12%
-0.60-0.28-47.48%
Q1 2022
Q2Q % growth
-0.57
47.22%
-0.690.1217.12%
Q4 2021
Q2Q % growth
0.48
122.86%
-0.120.60516.97%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth
1.125M
49.80%
30.6K1.094M3,576.47%
Q2 2022
Q2Q % growth

-100.00%
1.766M-1.766M-100.00%
Q1 2022
Q2Q % growth
2.551M
-12.64%
1.326M1.225M92.38%
Q4 2021
Q2Q % growth
17.499M
55.41%
10.176M7.323M71.96%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
RevenueN/A N/A 0.15% 0.15%